Hanyang Med Rev.  2017 Nov;37(2):49-60. 10.7599/hmr.2017.37.2.49.

Concepts, Characteristics, and Clinical Validation of IBM Watson for Oncology

Affiliations
  • 1Digital Healthcare Institute, Seoul, Korea. yoonsup.choi@gmail.com
  • 2Digital Healthcare Partners, Seoul, Korea.
  • 3Department of Digital Health, Sungkyunkwan University, Seoul, Korea.

Abstract

The development of artificial intelligence revolutionizes many fields, and one of the representative fields is medical artificial intelligence. The world-renowned IBM Watson for Oncology (WFO) is a leading medical artificial intelligence that recommends treatment options to doctors based on medical records of cancer patients. This review examines the concepts and characteristics of WFOs and the challenges to be addressed. In particular, the accuracy and medical efficacy of WFO have not yet been fully validated, and it will be necessary to establish evidence through further clinical studies. Artificial intelligence will make fundamental changes in many areas of medicine in the future. It is necessary for the medical community to establish principles of how to maximize clinical benefits and minimize side effects.

Keyword

Artificial intelligence; Clinical trials; Evidence based medicine; Cancer; Machine learning
Full Text Links
  • HMR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr